BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

198 related articles for article (PubMed ID: 25300705)

  • 1. Simvastatin induces mitochondrial dysfunction and increased atrogin-1 expression in H9c2 cardiomyocytes and mice in vivo.
    Bonifacio A; Mullen PJ; Mityko IS; Navegantes LC; Bouitbir J; Krähenbühl S
    Arch Toxicol; 2016 Jan; 90(1):203-15. PubMed ID: 25300705
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pharmacological activation of the pyruvate dehydrogenase complex reduces statin-mediated upregulation of FOXO gene targets and protects against statin myopathy in rodents.
    Mallinson JE; Constantin-Teodosiu D; Glaves PD; Martin EA; Davies WJ; Westwood FR; Sidaway JE; Greenhaff PL
    J Physiol; 2012 Dec; 590(24):6389-402. PubMed ID: 23045346
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Adenosine monophosphate-activated protein kinase attenuates cardiomyocyte hypertrophy through regulation of FOXO3a/MAFbx signaling pathway.
    Chen B; Wu Q; Xiong Z; Ma Y; Yu S; Chen D; Huang S; Dong Y
    Acta Biochim Biophys Sin (Shanghai); 2016 Sep; 48(9):827-32. PubMed ID: 27521792
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Atrogin-1/MAFbx enhances simulated ischemia/reperfusion-induced apoptosis in cardiomyocytes through degradation of MAPK phosphatase-1 and sustained JNK activation.
    Xie P; Guo S; Fan Y; Zhang H; Gu D; Li H
    J Biol Chem; 2009 Feb; 284(9):5488-96. PubMed ID: 19117950
    [TBL] [Abstract][Full Text] [Related]  

  • 5. 20(s)‑ginseonside‑Rg3 modulation of AMPK/FoxO3 signaling to attenuate mitochondrial dysfunction in a dexamethasone‑injured C2C12 myotube‑based model of skeletal atrophy
    Wang M; Jiang R; Liu J; Xu X; Sun G; Zhao D; Sun L
    Mol Med Rep; 2021 May; 23(5):. PubMed ID: 33649814
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Myocardial expression of FOXO3a-Atrogin-1 pathway in human heart failure.
    Galasso G; De Rosa R; Piscione F; Iaccarino G; Vosa C; Sorriento D; Piccolo R; Rapacciuolo A; Walsh K; Chiariello M
    Eur J Heart Fail; 2010 Dec; 12(12):1290-6. PubMed ID: 21098579
    [TBL] [Abstract][Full Text] [Related]  

  • 7. AMP-activated protein kinase enhances the expression of muscle-specific ubiquitin ligases despite its activation of IGF-1/Akt signaling in C2C12 myotubes.
    Tong JF; Yan X; Zhu MJ; Du M
    J Cell Biochem; 2009 Oct; 108(2):458-68. PubMed ID: 19639604
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Mechanisms involved in 3',5'-cyclic adenosine monophosphate-mediated inhibition of the ubiquitin-proteasome system in skeletal muscle.
    Gonçalves DA; Lira EC; Baviera AM; Cao P; Zanon NM; Arany Z; Bedard N; Tanksale P; Wing SS; Lecker SH; Kettelhut IC; Navegantes LC
    Endocrinology; 2009 Dec; 150(12):5395-404. PubMed ID: 19837877
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Atrogin-1 ubiquitin ligase is upregulated by doxorubicin via p38-MAP kinase in cardiac myocytes.
    Yamamoto Y; Hoshino Y; Ito T; Nariai T; Mohri T; Obana M; Hayata N; Uozumi Y; Maeda M; Fujio Y; Azuma J
    Cardiovasc Res; 2008 Jul; 79(1):89-96. PubMed ID: 18346979
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Atrogin-1 inhibits Akt-dependent cardiac hypertrophy in mice via ubiquitin-dependent coactivation of Forkhead proteins.
    Li HH; Willis MS; Lockyer P; Miller N; McDonough H; Glass DJ; Patterson C
    J Clin Invest; 2007 Nov; 117(11):3211-23. PubMed ID: 17965779
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Forkhead box O3 plays a role in skeletal muscle atrophy through expression of E3 ubiquitin ligases MuRF-1 and atrogin-1 in Cushing's syndrome.
    Kang SH; Lee HA; Kim M; Lee E; Sohn UD; Kim I
    Am J Physiol Endocrinol Metab; 2017 Jun; 312(6):E495-E507. PubMed ID: 28246104
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Susceptibility to simvastatin-induced toxicity is partly determined by mitochondrial respiration and phosphorylation state of Akt.
    Mullen PJ; Zahno A; Lindinger P; Maseneni S; Felser A; Krähenbühl S; Brecht K
    Biochim Biophys Acta; 2011 Dec; 1813(12):2079-87. PubMed ID: 21839782
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Physical inactivity induces the atrophy of skeletal muscle of rats through activating AMPK/FoxO3 signal pathway.
    Zhang SF; Zhang Y; Li B; Chen N
    Eur Rev Med Pharmacol Sci; 2018 Jan; 22(1):199-209. PubMed ID: 29364488
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cardioprotection by acetylcholine: a novel mechanism via mitochondrial biogenesis and function involving the PGC-1α pathway.
    Sun L; Zhao M; Yu XJ; Wang H; He X; Liu JK; Zang WJ
    J Cell Physiol; 2013 Jun; 228(6):1238-48. PubMed ID: 23139024
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A novel fission-independent role of dynamin-related protein 1 in cardiac mitochondrial respiration.
    Zhang H; Wang P; Bisetto S; Yoon Y; Chen Q; Sheu SS; Wang W
    Cardiovasc Res; 2017 Feb; 113(2):160-170. PubMed ID: 27794519
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A novel protective mechanism for mitochondrial aldehyde dehydrogenase (ALDH2) in type i diabetes-induced cardiac dysfunction: role of AMPK-regulated autophagy.
    Guo Y; Yu W; Sun D; Wang J; Li C; Zhang R; Babcock SA; Li Y; Liu M; Ma M; Shen M; Zeng C; Li N; He W; Zou Q; Zhang Y; Wang H
    Biochim Biophys Acta; 2015 Feb; 1852(2):319-31. PubMed ID: 24874076
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Extended regorafenib treatment can be linked with mitochondrial damage leading to cardiotoxicity.
    Boran T; Akyildiz AG; Jannuzzi AT; Alpertunga B
    Toxicol Lett; 2021 Jan; 336():39-49. PubMed ID: 33166663
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Impaired mitochondrial biogenesis due to dysfunctional adiponectin-AMPK-PGC-1α signaling contributing to increased vulnerability in diabetic heart.
    Yan W; Zhang H; Liu P; Wang H; Liu J; Gao C; Liu Y; Lian K; Yang L; Sun L; Guo Y; Zhang L; Dong L; Lau WB; Gao E; Gao F; Xiong L; Wang H; Qu Y; Tao L
    Basic Res Cardiol; 2013 May; 108(3):329. PubMed ID: 23460046
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Doxorubicin triggers bioenergetic failure and p53 activation in mouse stem cell-derived cardiomyocytes.
    Cunha-Oliveira T; Ferreira LL; Coelho AR; Deus CM; Oliveira PJ
    Toxicol Appl Pharmacol; 2018 Jun; 348():1-13. PubMed ID: 29653124
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Epigallocatechin gallate prevents mitochondrial impairment and cell apoptosis by regulating miR-30a/p53 axis.
    Zhang C; Liao P; Liang R; Zheng X; Jian J
    Phytomedicine; 2019 Aug; 61():152845. PubMed ID: 31029907
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.